Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Bioscience Reports|December 11, 2020
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potentialZubair Ahmed Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, et al.Radiation Research|July 4, 2014
Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in miceMarka R Crittenden, Talicia Savage, Benjamin Cottam, et al.European Cytokine Network|November 30, 2010
Role of mitogen-activated protein kinase and PI3K pathways in the regulation of IL-12-family cytokines in dendritic cells and the generation of T H-responsesAndrew M Jackson, Lori A Mulcahy, Joanne Porte, et al.Cell Transplantation|June 8, 2010
Assessment of islet quality following international shipping of more than 10,000 kmTetsuya Ikemoto, Shinichi Matsumoto, Takeshi Itoh, et al.International Journal of Cancer|September 24, 2004
Cytokine-modified Mycobacterium smegmatis as a novel anticancer immunotherapySarah L Young, Michael Murphy, Xing Wu Zhu, et al.Plos One|August 13, 2013
The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumorMarka R Crittenden, Talicia Savage, Benjamin Cottam, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2013
The ataxia telangiectasia mutated kinase pathway regulates IL-23 expression by human dendritic cellsQunwei Wang, Hester A Franks, Stephanie J Lax, et al.Journal of Leukocyte Biology|April 7, 2016
Stromal fibroblasts support dendritic cells to maintain IL-23/Th17 responses after exposure to ionizing radiationAnna Malecka, Qunwei Wang, Sabaria Shah, et al.Breast Cancer Research : BCR|November 19, 2008
IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell linesXingWu Zhu, Lori A Mulcahy, Rabab A A Mohammed, et al.Cancer Immunology, Immunotherapy : CII|November 16, 2023
Targeting alternative splicing as a new cancer immunotherapy-phosphorylation of serine arginine-rich splicing factor (SRSF1) by SR protein kinase 1 (SRPK1) regulates alternative splicing of PD1 to generate a soluble antagonistic isoform that prevents T cell exhaustionMussarat Wahid, Benjamart Pratoomthai, Isioma U Egbuniwe, et al.Pageof 7